Prognostic Value of Pretreatment Carcinoembryonic Antigen (CEA) in Rectal Cancer Treated with Preoperative Short-Course Radiotherapy with Delayed Surgery or Long-Course Radiotherapy.

Onco Targets Ther

Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung City, 833, Taiwan.

Published: January 2025

Purpose: To investigate the prognostic value of the pretreatment serum carcinoembryonic antigen (CEA) level in patients with rectal cancer treated by preoperative short-course radiotherapy (SCRT) followed by chemotherapy and delayed surgery.

Patients And Methods: Two hundred and sixty-six consecutive patients with locally advanced rectal adenocarcinoma without distant metastasis receiving preoperative radiotherapy were enrolled. Group 1 patients (n=144) received long-course radiotherapy (LCRT) with 50.4 Gy in 28 fractions using photon radiotherapy (XRT). Group 2 patients (n=122) received SCRT with 25 Gy in 5 fractions using XRT or proton beam therapy (PBT) followed by chemotherapy and delayed surgery. Pathological complete response (pCR), near pathological complete response (npCR), locoregional recurrence (LRR), distant metastasis (DM), disease-specific survival (DSS) and overall survival (OS) rates were estimated and compared to scrutinize the prognostic significance of factors including CEA level.

Results: In group 1, higher CEA level (≥ 7 ng/mL) was a significant negative prognostic factor of pCR ( = 0.003, OR: 0.133), OS ( = 0.011, HR: 2.999), DM ( = 0.008, HR: 2.569), LRR ( = 0.044, HR: 3.160), and DSS ( = 0.015, HR: 3.273). In group 2, higher CEA level (≥ 7 ng/mL) was a significant negative prognostic factor of pCR ( = 0.002, OR: 0.038), OS ( < 0.001, HR: 44.658), DM ( < 0.001, HR: 8.926), LRR ( = 0.028, HR: 8.570), and DSS ( = 0.001, HR: 43.918). The npCR rates for clinical T4 patients were 6.5% and 22.0% ( = 0.032), in group 1 and group 2, respectively.

Conclusion: This study elucidates the prognostic merit of the pretreatment serum CEA level in patients with rectal cancer treated by either preoperative LCRT or SCRT followed by chemotherapy and delayed surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748052PMC
http://dx.doi.org/10.2147/OTT.S474855DOI Listing

Publication Analysis

Top Keywords

cea level
16
rectal cancer
12
cancer treated
12
treated preoperative
12
delayed surgery
12
chemotherapy delayed
12
prognostic pretreatment
8
carcinoembryonic antigen
8
antigen cea
8
preoperative short-course
8

Similar Publications

A Rare Case of Colorectal Cancer With Delayed Metastasis to the Duodenum.

Case Rep Gastrointest Med

January 2025

Department of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan 48202, USA.

Colorectal cancer (CRC) continues to be a significant global health issue contributing to a high mortality rate. Despite advancements in treatment, the risk of recurrence remains due to inherent mutations and the rapid turnover of intestinal mucosa. We present an exceptionally rare case of CRC metastasis to the duodenum in a 42-year-old female who has been compliant with postsurgical surveillance.

View Article and Find Full Text PDF

Prognostic Value of Pretreatment Carcinoembryonic Antigen (CEA) in Rectal Cancer Treated with Preoperative Short-Course Radiotherapy with Delayed Surgery or Long-Course Radiotherapy.

Onco Targets Ther

January 2025

Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung City, 833, Taiwan.

Purpose: To investigate the prognostic value of the pretreatment serum carcinoembryonic antigen (CEA) level in patients with rectal cancer treated by preoperative short-course radiotherapy (SCRT) followed by chemotherapy and delayed surgery.

Patients And Methods: Two hundred and sixty-six consecutive patients with locally advanced rectal adenocarcinoma without distant metastasis receiving preoperative radiotherapy were enrolled. Group 1 patients (n=144) received long-course radiotherapy (LCRT) with 50.

View Article and Find Full Text PDF

Background: Ticks, hematophagous Acari, pose a significant threat by transmitting various pathogens to their vertebrate hosts during feeding. Despite advances in tick genomics, high-quality genomes were lacking until recently, particularly in the genus Ixodes, which includes the main vectors of Lyme disease.

Results: Here, we present the genome sequences of four tick species, derived from a single female individual, with a particular focus on the European species Ixodes ricinus, achieving a chromosome-level assembly.

View Article and Find Full Text PDF

Approximately two-thirds of patients with colorectal cancer (CRC) undergo resection with curative intent; however, 30% to 50% of these patients experience recurrence. The concentration of cell-free DNA (cfDNA) before and after surgery may be related to the prognosis of patients with CRC, but there is limited information regarding cfDNA levels at the time of surgery. Here, we analyzed surgical cfDNA release using plasma samples from 30 colorectal cancer patients at three key points during surgery: preoperative (immediately before surgery), intraoperative (during surgery), and postoperative (at the end of surgery).

View Article and Find Full Text PDF

Optimizing photosynthetic lighting is essential for maximizing crop production and minimizing electricity costs in controlled environment agriculture (CEA). Traditional lighting methods often neglect the impact of environmental factors, crop type, and light acclimation on photosynthetic efficiency. To address this, a chlorophyll fluorescence-based biofeedback system was developed to adjust light-emitting diode (LED) intensity based on real-time plant responses, rather than using a fixed photosynthetic photon flux density (PPFD).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!